Point72 Hong Kong’s Syndax Pharmaceuticals SNDX Stock Holding History

Point72 Hong Kong’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$674K	Buy	+43,809	New	+$573K	0.03%	245
2022 Q2	–	Sell	-2,350	Closed	-$41K	–	2362
2022 Q1	$41K	Buy	+2,350	New	+$39.6K	﹤0.01%	1384
2021 Q4	–	Sell	-653	Closed	-$12K	–	2345
2021 Q3	$12K	Sell	653 -3,330	-84%	-$55.5K	﹤0.01%	1779
2021 Q2	$68K	Buy	3,983 +3,635	+1,045%	+$66.6K	﹤0.01%	1408
2021 Q1	$8K	Buy	+348	New	+$7.86K	﹤0.01%	1613
2020 Q4	–	Sell	-190	Closed	-$3K	–	2022
2020 Q3	$3K	Sell	190 -5,508	-97%	-$84K	﹤0.01%	1106
2020 Q2	$84K	Buy	+5,698	New	+$86.8K	0.01%	664

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Point72 Hong Kong's SNDX Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Syndax Pharmaceuticals (SNDX) in Q3 2025: 43,809 shares worth $674K. The stake represents 0.03% of the portfolio and ranks #245 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in SNDX as recently as Q1 2022.

Point72 Hong Kong first reported a position in SNDX in Q2 2020 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold SNDX as of Q3 2025.

Point72 Hong Kong held 43,809 shares of Syndax Pharmaceuticals worth $674K as of Q3 2025.
Syndax Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
Syndax Pharmaceuticals made up 0.03% of Point72 Hong Kong's portfolio in Q3 2025, its #245 holding.
Point72 Hong Kong first reported a position in Syndax Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
227 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.